WALTHAM, Mass.--(BUSINESS WIRE)--July 27, 2006--NeuroMetrix, Inc. (Nasdaq: NURO - News), a medical device company focused on the design, development and sale of proprietary products used to diagnose neuropathies, or diseases of the nerves, announced today the financial results for the three and six month periods ended June 30, 2006.
